Literature DB >> 15823672

Mitochondrial neuropathy.

Josef Finsterer1.   

Abstract

Polyneuropathy is a frequent feature of mitochondriopathy (MCP). If and how often polyneuropathy in MCP is primarily due to the underlying disorder (mitochondrial neuropathy, MN) or due to other well-known causes is unknown. Retrospectively investigated were 108 MCP-patients with polyneuropathy. According to established diagnostic criteria 37 patients were classified as definite MCP, 56 as probable MCP and 15 as possible MCP. In 38 of the 108 MCP-patients with polyneuropathy (35%), no plausible cause for polyneuropathy other than MCP could be found. MN was characterized by weakness, muscle cramps, wasting, reduced tendon reflexes, muscle pain, ataxia, restless legs, hypesthesia, paresthesia, dysesthesia, and vegetative impairment. In 21 cases predominantly motor fibers, in 14 cases both motor and sensory fibers and in 3 cases predominantly sensory fibers were affected. Axonal degeneration was found in 19 cases, demyelination in 4 and mixed-type polyneuropathy in 15. On sural nerve biopsy axonal loss was the predominant finding. In a single case tomaculae and abnormally shaped and structured mitochondria were found. MN exists, occurs in one third of the MCP-patients with polyneuropathy, and is characterized by predominant affection of the motor and sensory fibers with diffuse, symmetric and equal distribution between upper and lower limbs and by axonal degeneration.

Entities:  

Mesh:

Year:  2005        PMID: 15823672     DOI: 10.1016/j.clineuro.2004.07.001

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study.

Authors:  Michelangelo Mancuso; Selina Piazza; Leda Volpi; Daniele Orsucci; Valeria Calsolaro; Elena Caldarazzo Ienco; Cecilia Carlesi; Anna Rocchi; Lucia Petrozzi; Rosanna Calabrese; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2011-07-13       Impact factor: 3.307

Review 2.  Molecular genetics of autosomal-recessive axonal Charcot-Marie-Tooth neuropathies.

Authors:  Rafaëlle Bernard; Annachiara De Sandre-Giovannoli; Valérie Delague; Nicolas Lévy
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 3.  Acetyl-L-carnitine in neuropathic pain: experimental data.

Authors:  Santina Chiechio; Agata Copani; Robert W Gereau; Ferdinando Nicoletti
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Proliferator-Activated Receptor-Gamma Coactivator-1α Haploinsufficiency Promotes Pain Chronification After Burn Injury.

Authors:  Jiamin Miao; Xue Zhou; Weihua Ding; Zerong You; Jason Doheny; Wei Mei; Qian Chen; Jianren Mao; Shiqian Shen
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

5.  Mitochondrial multiorgan disorder syndrome score generated from definite mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-06       Impact factor: 2.570

6.  Expanding the genotype-phenotype correlation of childhood sensory polyneuropathy of genetic origin.

Authors:  Samya Chakravorty; Rachel Logan; Molly J Elson; Rebecca R Luke; Sumit Verma
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.